Innovation Pharmaceuticals Inc (IPIX)

[Hugon]

What do you make about Degrado saying Herapin use significantly reduces antiviral efficacy of brilaicin and that Herapin is given with brilaicin in trial clinical sites? Just being rose colored hopeful and dismissive of William Degrado’s study findings is a bit odd unless you know more than he does, which is true you’d be a National Academy of Science member. Lol

The truth is: nothing matters now. What done is done.

It’s data reveal time, but sure hope they don’t mention Herapin as their excuse if it fails.

Hope it doesn’t and goes to $5